Literature DB >> 3787545

Legionnaires' disease: a review of 79 community acquired cases in Nottingham.

M A Woodhead, J T Macfarlane.   

Abstract

Seventy nine cases of sporadic, community acquired legionnaires' disease have been reviewed. Annual and seasonal variation in incidence was noted. The mean age of the patients was 53 years and 50 (63%) were male. Pre-existing chronic diseases were present in only 23 (29%), including two patients receiving immunosuppressive treatment. Common symptoms included unproductive cough, dyspnoea, chest pain, headache, confusion, nausea, vomiting, and diarrhoea. Respiratory symptoms were absent, however, in 17 (22%). Localising chest signs were present in 74 (95%) cases. Frequent laboratory findings included lymphopenia, high erythrocyte sedimentation rate, hyponatraemia, raised urea and creatinine concentrations, abnormal liver function, hypophosphataemia, hypoalbuminaemia, proteinuria, and haematuria. Thirteen patients died (16%), including nine of 20 who received assisted ventilation. The mortality rate in patients treated with erythromycin (11%) was lower than in those who received other antibiotics (23%), but this difference was not statistically significant. Of the features noted on admission, only a high plasma urea concentration was significantly associated with death. Sporadic community acquired legionnaires' disease is a not uncommon disorder, which with appropriate treatment has a prognosis similar to that of other forms of community acquired pneumonia.

Entities:  

Mesh:

Year:  1986        PMID: 3787545      PMCID: PMC460410          DOI: 10.1136/thx.41.8.635

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  25 in total

1.  Pneumococcal antigen in pneumonia. A post-mortem study with the histological and bacteriological findings.

Authors:  M El-Refaie; R Tait; C Dulake; F E Dische
Journal:  Postgrad Med J       Date:  1976-08       Impact factor: 2.401

2.  Legionnaires' disease bacterium isolated in 1947.

Authors:  J E McDade; D J Brenner; F M Bozeman
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

3.  Formalised yolk sac antigen in early diagnosis of Legionnaires' disease caused by Legionella pneumophila serogroup 1.

Authors:  A G Taylor; T G Harrison
Journal:  Lancet       Date:  1981-09-12       Impact factor: 79.321

4.  Causes of pneumonia presenting to a district general hospital.

Authors:  R J White; A D Blainey; K J Harrison; S K Clarke
Journal:  Thorax       Date:  1981-08       Impact factor: 9.139

5.  Legionnaires' disease: clinical features of the epidemic in Philadelphia.

Authors:  T F Tsai; D R Finn; B D Plikaytis; W McCauley; S M Martin; D W Fraser
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

6.  Early clinical differentiation between Legionnaires' disease and other sporadic pneumonias.

Authors:  A C Miller
Journal:  Ann Intern Med       Date:  1979-04       Impact factor: 25.391

7.  Susceptibility of Legionella pneumophila to twenty antimicrobial agents.

Authors:  P H Edelstein; R D Meyer
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

Review 8.  Legionnaires' disease: report of sixty-five nosocomially acquired cases of review of the literature.

Authors:  B D Kirby; K M Snyder; R D Meyer; S M Finegold
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

9.  Sporadic Legionnaires' disease. A pathologic study of 23 fatal cases.

Authors:  D D Weisenburger; C M Helms; E D Renner
Journal:  Arch Pathol Lab Med       Date:  1981-03       Impact factor: 5.534

Review 10.  The protean manifestations of Legionnaires' disease.

Authors:  M A Woodhead; J T Macfarlane
Journal:  J R Coll Physicians Lond       Date:  1985-10
View more
  9 in total

1.  Extremely elevated erythrocyte sedimentation rates (ESRs) in Legionnaires' disease.

Authors:  B A Cunha; S Strollo; P Schoch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-22       Impact factor: 3.267

Review 2.  Bacterial challenges and evolving antibacterial drug strategy.

Authors:  B Watt; J G Collee
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

Review 3.  Treatment of hypophosphatemia in the intensive care unit: a review.

Authors:  Daniël A Geerse; Alexander J Bindels; Michael A Kuiper; Arnout N Roos; Peter E Spronk; Marcus J Schultz
Journal:  Crit Care       Date:  2010-08-03       Impact factor: 9.097

4.  Nosocomial outbreak of legionellosis in a rehabilitation center. Demonstration of potable water as a source.

Authors:  R Nechwatal; W Ehret; O J Klatte; H J Zeissler; A Prull; H Lutz
Journal:  Infection       Date:  1993 Jul-Aug       Impact factor: 3.553

5.  Legionella pneumonia cases over a five-year period: a descriptive, retrospective study of outcomes in a UK district hospital.

Authors:  Tom Wingfield; Sam Rowell; Alex Peel; Deeksha Puli; Achyut Guleri; Rashmi Sharma
Journal:  Clin Med (Lond)       Date:  2013-04       Impact factor: 2.659

6.  Legionnaires' Disease: Clinicoradiological Comparison of Sporadic Versus Outbreak Cases.

Authors:  Hafiz Rizwan Talib Hashmi; Lakshmi Saladi; Frances Petersen; Misbahuddin Khaja; Gilda Diaz-Fuentes
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2017-06-06

7.  A Case of Legionella Pneumonia in an Older Patient Without Typical Exposure to a Susceptive Environment.

Authors:  Yasuhisa Nakano; Kota Saka; Fumiko Yamane; Chiaki Sano; Ryuichi Ohta
Journal:  Cureus       Date:  2022-07-31

8.  Dynamics of peripheral blood lymphocyte subpopulations in the acute and subacute phase of Legionnaires' disease.

Authors:  Cornelis P C de Jager; Eugenie F A Gemen; Jacqueline Leuvenink; Mirrian Hilbink; Robert J F Laheij; Tom van der Poll; Peter C Wever
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

9.  Hyperphosphatemia Is an Independent Risk Factor for Mortality in Critically Ill Patients: Results from a Cross-Sectional Study.

Authors:  Dominik G Haider; Gregor Lindner; Michael Wolzt; Sufian S Ahmad; Thomas Sauter; Alexander Benedikt Leichtle; Georg-Martin Fiedler; Valentin Fuhrmann; Aristomenis K Exadaktylos
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.